Genetic and Probiotic Characteristics of Urolithin A Producing Enterococcus faecium FUA027. 2023

Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Jiangsu Ocean University, Lianyungang 222005, China.

Enterococcus faecium FUA027 transforms ellagic acid (EA) to urolithin A (UA), which makes it a potential application in the preparation of UA by industrial fermentation. Here, the genetic and probiotic characteristics of E. faecium FUA027 were evaluated through whole-genome sequence analysis and phenotypic assays. The chromosome size of this strain was 2,718,096 bp, with a GC content of 38.27%. The whole-genome analysis revealed that the genome contained 18 antibiotic resistance genes and seven putative virulence factor genes. E. faecium FUA027 does not contain plasmids and mobile genetic elements (MGEs), and so the transmissibility of antibiotic resistance genes or putative virulence factors should not occur. Phenotypic testing further indicated that E. faecium FUA027 is sensitive to clinically relevant antibiotics. In addition, this bacterium exhibited no hemolytic activity, no biogenic amine production, and could significantly inhibit the growth of the quality control strain. In vitro viability was >60% in all simulated gastrointestinal environments, with good antioxidant activity. The study results suggest that E. faecium FUA027 has the potential to be used in industrial fermentation for the production of urolithin A.

UI MeSH Term Description Entries

Related Publications

Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
November 2019, Folia microbiologica,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
October 2022, Life (Basel, Switzerland),
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
December 2020, Probiotics and antimicrobial proteins,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
January 2022, Frontiers in nutrition,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
March 2019, Microbial pathogenesis,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
January 2017, Frontiers in microbiology,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
October 2009, Journal of applied microbiology,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
January 2006, Anaerobe,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
January 2018, New microbes and new infections,
Mengjie Xia, and Shuting Mu, and Yaowei Fang, and Xiaomeng Zhang, and Guang Yang, and Xiaoyue Hou, and Fuxiang He, and Yaling Zhao, and Yichen Huang, and Wei Zhang, and Juan Shen, and Shu Liu
January 2023, Frontiers in microbiology,
Copied contents to your clipboard!